NCT07618845尚未招募1 期
A Randomized, Open-label, 2-period, 2-sequence, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of AD-230 in Healthy Adult Volunteers
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 24
- 试验地点
- 1
研究概览
简要总结
A clinical trial to assess the pharmacokinetics, safety, and food effect of AD-230 in healthy adults
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 64 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Body mass index (BMI) between 18.5 kg/m2 and 29.9 kg/m2 at the time of screening visit
- •Subjects aged 19 years or older and under 65 years at the screening visit
排除标准
- •Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
- •Other exclusions applied
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
1 期
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy AdultsChronic Liver Disease (CLD)NCT07521241Addpharma Inc.52
尚未招募
1 期
A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231CDyslipidemiaHypertensionNCT07590167Addpharma Inc.60
尚未招募
1 期
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232Diabetes MellitusNCT07538466Addpharma Inc.50
尚未招募
1 期
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult SubjectsChronic Heart FailureNCT07476157Addpharma Inc.70
尚未招募
1 期
Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322HypertensionNCT07312799Addpharma Inc.41